Table 2. Cancers used in this study with the number of samples sequenced of both tumour biopsy and normal adjacent tissue.
| TCGA Identifier | Cancer | Primary tumor | Normal adjacent tissue | Ref. |
|---|---|---|---|---|
| BLCA | Bladder Urothelial Carcinoma | 301 | 17 | [29] |
| BRCA | Breast invasive carcinoma | 1057 | 113 | [30] |
| COAD | Colon adenocarcinoma | 451 | 41 | [31] |
| HNSC | Head and Neck squamous cell carcinoma | 480 | 42 | [32] |
| KIRC | Kidney renal clear cell carcinoma | 526 | 72 | [19] |
| KIRP | Kidney renal papillary cell carcinoma | 222 | 32 | [33] |
| LIHC | Liver hepatocellular carcinoma | 294 | 48 | - |
| LUAD | Lung adenocarcinoma | 486 | 55 | [34] |
| LUSC | Lung squamous cell carcinoma | 428 | 45 | [35] |
| PRAD | Prostate adenocarcinoma | 379 | 52 | [36] |
| THCA | Thyroid carcinoma | 500 | 58 | [37] |
| UCEC | Uterine Corpus Endometrial Carcinoma | 516 | 23 | [38] |